APA (7th ed.) Citation

Borgenvik, A., Čančer, M., Hutter, S., & Swartling, F. J. (2021). Targeting MYCN in Molecularly Defined Malignant Brain Tumors. Frontiers in oncology, 10, 626751. https://doi.org/10.3389/fonc.2020.626751

Chicago Style (17th ed.) Citation

Borgenvik, Anna, Matko Čančer, Sonja Hutter, and Fredrik J. Swartling. "Targeting MYCN in Molecularly Defined Malignant Brain Tumors." Frontiers in Oncology 10 (2021): 626751. https://doi.org/10.3389/fonc.2020.626751.

MLA (9th ed.) Citation

Borgenvik, Anna, et al. "Targeting MYCN in Molecularly Defined Malignant Brain Tumors." Frontiers in Oncology, vol. 10, 2021, p. 626751, https://doi.org/10.3389/fonc.2020.626751.